Spectral domain optical coherence tomography features of multiple subfoveal retinal pigment epithelial tears after intravitreal bevacizumab.
dc.contributor.author | Chalam, Kakarla V | |
dc.contributor.author | Murthy, Ravi K | |
dc.contributor.author | Gupta, Shailesh K | |
dc.contributor.author | Brar, Vikram S | |
dc.date.accessioned | 2011-12-27T04:09:33Z | |
dc.date.available | 2011-12-27T04:09:33Z | |
dc.date.issued | 2011-01 | |
dc.description.abstract | Retinal pigment epithelial (RPE) tear has been described to occur spontaneously, after laser photocoagulation and in recent times, after intravitreal injection of anti-vascular endothelial growth factor (VEGF) agents. In the latter case, the rapid contraction of the choroidal vascular membrane underneath a serous RPE detachment is believed to be the underlying cause. Preservation of good visual acuity after the occurrence of RPE tear with continued use of intravitreal VEGF agents has been reported. In this case report, we describe the occurrence of multiple RPE tears with the use of intravitreal bevacizumab and also correlate the preservation of visual acuity with features seen on spectral domain optical coherence tomography. | en_US |
dc.identifier.citation | Chalam Kakarla V, Murthy Ravi K, Gupta Shailesh K, Brar Vikram S. Spectral domain optical coherence tomography features of multiple subfoveal retinal pigment epithelial tears after intravitreal bevacizumab. Indian Journal of Ophthalmology. 2011 Jan; 59(1): 47-48. | en_US |
dc.identifier.uri | https://imsear.searo.who.int/handle/123456789/136137 | |
dc.language.iso | en | en_US |
dc.source.uri | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3032242/ | en_US |
dc.subject | Bevacizumab | en_US |
dc.subject | retinal pigment epithelial tear | en_US |
dc.subject | spectral domain optical coherence tomography | en_US |
dc.subject.mesh | Aged | |
dc.subject.mesh | Angiogenesis Inhibitors --administration & dosage | |
dc.subject.mesh | Angiogenesis Inhibitors --adverse effects | |
dc.subject.mesh | Antibodies, Monoclonal --administration & dosage | |
dc.subject.mesh | Antibodies, Monoclonal --adverse effects | |
dc.subject.mesh | Antibodies, Monoclonal, Humanized | |
dc.subject.mesh | Female | |
dc.subject.mesh | Fundus Oculi | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Intravitreal Injections | |
dc.subject.mesh | Macular Degeneration --complications | |
dc.subject.mesh | Macular Degeneration --drug therapy | |
dc.subject.mesh | Macular Degeneration --physiopathology | |
dc.subject.mesh | Retinal Perforations --chemically induced | |
dc.subject.mesh | Retinal Perforations --diagnosis | |
dc.subject.mesh | Tomography, Optical Coherence | |
dc.subject.mesh | Vision Disorders --etiology | |
dc.subject.mesh | Visual Acuity | |
dc.title | Spectral domain optical coherence tomography features of multiple subfoveal retinal pigment epithelial tears after intravitreal bevacizumab. | en_US |
dc.type | Article | en_US |